These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36339206)

  • 41. Pneumonia Frequency and Severity in Patients With Symptomatic COVID-19: Impact of mRNA and Adenovirus Vector Vaccines.
    Vicini S; Bellini D; Iannarelli A; Rengo M; Pelle G; Ruggiero S; Fusco M; Ambrogi C; Carbone I
    AJR Am J Roentgenol; 2022 Nov; 219(5):752-761. PubMed ID: 35642761
    [No Abstract]   [Full Text] [Related]  

  • 42. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.
    Kerr S; Vasileiou E; Robertson C; Sheikh A
    J Glob Health; 2022 Jul; 12():05025. PubMed ID: 35802764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody response to SARS-CoV-2 vaccines among hospitalized patients in China: a case-control study.
    Li FP; Shi GF; Lin ZZ; Zhu XL; Wang LJ; Tung TH; Zhang MX
    Hum Vaccin Immunother; 2022 Nov; 18(5):2088966. PubMed ID: 35708313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thoracic imaging tests for the diagnosis of COVID-19.
    Islam N; Salameh JP; Leeflang MM; Hooft L; McGrath TA; van der Pol CB; Frank RA; Kazi S; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Wang J; McInnes MD;
    Cochrane Database Syst Rev; 2020 Nov; 11():CD013639. PubMed ID: 33242342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
    Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics and changes of chest CT features in 307 patients with common COVID-19 pneumonia infected SARS-CoV-2: A multicenter study in Jiangsu, China.
    Shang Y; Xu C; Jiang F; Huang R; Li Y; Zhou Y; Xu F; Dai H
    Int J Infect Dis; 2020 Jul; 96():157-162. PubMed ID: 32423888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS-CoV-2 Delta variant dominant period and their clinical characteristics.
    Özüdoğru O; Acer Ö; Genç Bahçe Y
    J Med Virol; 2022 Aug; 94(8):3706-3713. PubMed ID: 35419851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
    Glintborg B; Jensen DV; Terslev L; Hendricks O; Østergaard M; Rasmussen SH; Jensen MP; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Sørensen CM; Krogh NS; Agerbo JN; Ziegler C; Hetland ML
    J Rheumatol; 2022 Oct; 49(10):1163-1172. PubMed ID: 35705237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
    Wu D; Ye Y; Tang L; Wang AB; Zhang R; Qian ZH; Wang FZ; Zheng H; Huang C; Lv XY; Wang HF; Zhang YY; Pan JJ; Li YF; Lu MX; Wang CS; Ma YT; An ZJ; Rodewald LE; Yin ZD; Wang XY; Wu ZY; Shao YM
    Emerg Microbes Infect; 2022 Dec; 11(1):1950-1958. PubMed ID: 35850623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
    Corchado-Garcia J; Zemmour D; Hughes T; Bandi H; Cristea-Platon T; Lenehan P; Pawlowski C; Bade S; O'Horo JC; Gores GJ; Williams AW; Badley AD; Halamka J; Virk A; Swift MD; Wagner T; Soundararajan V
    JAMA Netw Open; 2021 Nov; 4(11):e2132540. PubMed ID: 34726743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans.
    Young-Xu Y; Korves C; Roberts J; Powell EI; Zwain GM; Smith J; Izurieta HS
    JAMA Netw Open; 2021 Oct; 4(10):e2128391. PubMed ID: 34613401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience.
    Strickler SS; Esper A; Wells L; Wood A; Frediani JK; Nehl E; Waggoner JJ; Rebolledo PA; Levy JM; Figueroa J; Ramachandra T; Lam W; Martin GS
    Front Med (Lausanne); 2022; 9():1031083. PubMed ID: 36507539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?].
    Kara E; Tanır F; Demirhindi H; Mete B; Kibar F; Çetiner S; Candevir A; İnaltekin A
    Mikrobiyol Bul; 2022 Jul; 56(3):566-573. PubMed ID: 35960246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rate of True-Positive Findings of COVID-19 Typical Appearance at Chest CT per RSNA Consensus Guidelines in an Increasingly Vaccinated Population.
    Polyakov NJ; Som A; Mercaldo ND; Di Capua J; Little BP; Flores EJ
    Radiology; 2023 Mar; 306(3):e220680. PubMed ID: 36066367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
    Guven DC; Sahin TK; Akın S; Uckun FM
    Oncologist; 2022 Apr; 27(4):e357-e361. PubMed ID: 35274729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease - A cross-sectional study in Hungary.
    Fekete M; Horvath A; Santa B; Tomisa G; Szollosi G; Ungvari Z; Fazekas-Pongor V; Major D; Tarantini S; Varga JT
    Vaccine; 2023 Jan; 41(1):193-200. PubMed ID: 36424256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.